Weinberg, Andrew D <br/><br/>
OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccines.  [electronic resource] 

 -  Trends in immunology  Feb 2002 
 - 102-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1471-4906 
<br/><br/><label>Standard No.: </label>10.1016/s1471-4906(01)02127-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Autoimmunity--immunology<br/>Humans<br/>Immunotherapy<br/>Membrane Glycoproteins--immunology<br/>OX40 Ligand<br/>Receptors, OX40<br/>Receptors, Tumor Necrosis Factor<br/>T-Lymphocytes--immunology<br/>Tumor Necrosis Factor Receptor Superfamily, Member 7--immunology<br/>Vaccines--immunology